At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 857 enrolled
Drug / intervention
Pitavastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
In Brief
A Phase 3 clinical trial evaluating Pitavastatin and Simvastatin for Hypercholesterolemia and Dyslipidemia. Completed, enrolled 857 participants across 42 sites in 5 countries.
Detailed Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia, Dyslipidemia
CountriesFinland, Italy, Norway, Russia, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2005
First PostedApr 2006
Primary CompletionOct 2006
TodayJul 2026
First PostedApr 3, 2006
Enrollment StartSep 1, 2005
Primary CompletionOct 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.2 years ago
Interventions
Pitavastatindrug
Pitavastatin once daily
Simvastatindrug
Simvastatin once daily